Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Virus-like particles as immunogens.

Rob Noad1, Polly Roy

  • 1Dept of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.

Trends in Microbiology
|September 19, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Molecular and Structural Perspective on Bluetongue Virus Entry and Assembly.

Pathogens (Basel, Switzerland)·2026
Same author

Visualization of Bluetongue Virus RNA Segment Networks in Infected Cells: Multipartite Genomic RNA Assortment Is Independent of Viral Proteins NS2 and VP6.

Viruses·2026
Same author

Insect-borne non-enveloped bluetongue virus utilizes discrete small vesicles for non-lytic release and cell-to-cell transmission.

PLoS pathogens·2025
Same author

Visualization and tracking of tubule-derived, fluorescent-labeled NS1 as a marker of bluetongue virus in living cells.

Journal of virology·2025
Same author

Challenges in developing a split drive targeting dsx for the genetic control of the invasive malaria vector Anopheles stephensi.

Parasites & vectors·2025
Same author

Impact of VP2 structure on antigenicity: comparison of BTV1 and the highly virulent BTV8 serotype.

Journal of virology·2024
Same journal

Structural inequalities in global antimicrobial resistance governance.

Trends in microbiology·2026
Same journal

Environmental microbes as modulators of plant volatile landscapes: Implications for plant-insect chemical communication.

Trends in microbiology·2026
Same journal

Beyond AMGs: Phage-encoded transcription and sigma factors as understudied virocell reprogramming tools.

Trends in microbiology·2026
Same journal

Cronobacter spp.

Trends in microbiology·2026
Same journal

Anaerobic lignin deconstruction: A game changer for lignocellulosic biorefineries.

Trends in microbiology·2026
Same journal

Critical role of the inflammatory rheostat in influenza-associated pulmonary aspergillosis.

Trends in microbiology·2026
See all related articles

Virus-like particles (VLPs) are effective subunit vaccines that mimic virus structures for enhanced immune recognition. This review covers their current status, production challenges, and characteristics for various viral vaccine candidates.

Area of Science:

  • Vaccinology
  • Virology
  • Biotechnology

Background:

  • Subunit vaccines using recombinant proteins often face challenges with protein folding and immune presentation, leading to poor immunogenicity.
  • Virus-like particles (VLPs) are a unique class of subunit vaccines that structurally resemble authentic viruses.
  • VLPs offer improved antigen presentation in a native conformation, enhancing immune system recognition.

Purpose of the Study:

  • To review the current status and effectiveness of virus-like particles (VLPs) as vaccine candidates.
  • To discuss the characteristics of VLPs derived from different viruses.
  • To identify and address the problems associated with the production of VLPs for vaccine development.

Main Methods:

  • Literature review of existing studies on VLP vaccine development.

Related Experiment Videos

  • Analysis of VLP structural mimicry and immune response.
  • Discussion of VLP production methodologies and associated challenges.

    • Main Results:

    • VLPs demonstrate dramatic effectiveness as candidate vaccines due to their structural integrity and antigen presentation.
    • VLPs are readily recognized by the immune system, overcoming limitations of other subunit vaccines.
    • The review synthesizes current knowledge on VLP applications across various viral targets.

    Conclusions:

    • VLPs represent a highly promising platform for vaccine development, offering superior immunogenicity compared to traditional subunit vaccines.
    • Addressing production challenges is crucial for the widespread application of VLPs against diverse viral pathogens.
    • Further research into VLP characteristics and manufacturing will accelerate their clinical translation.